Back
Sarepta Therapeutics Stock Price Chart
$50 trade to make today with huge potential!
Click here to access my #1 options strategy for overnight wins starting with $50!
Buy
53
SRPT
Sarepta Therapeutics
Last Price:
133.68
Seasonality Move:
16.32%
7 Day Trial
ALL ACCESS PASS
$
7
America's Final Republican President
Click here to see his 2024 election prediction.- Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and SRPT is experiencing selling pressure, which indicates risk of future bearish movement.
Sarepta Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 126.77 | Buy |
| 20-day SMA: | 123.47 | Buy |
| 50-day SMA: | 125.78 | Buy |
| 200-day SMA: | 112.03 | Buy |
| 8-day EMA: | 127.12 | Buy |
| 20-day EMA: | 125.01 | Buy |
| 50-day EMA: | 123.64 | Buy |
| 200-day EMA: | 116.53 | Buy |
Sarepta Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.1 | Buy |
| Relative Strength Index (14 RSI): | 62.61 | Buy |
| Chaikin Money Flow: | -1849311 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (119.44 - 129.14) | Buy |
| Bollinger Bands (100): | (105.04 - 131.84) | Buy |
Sarepta Therapeutics Technical Analysis
| Apr 19 | Apr 22 | Apr 23 | Apr 24 | Apr 25 | Apr 26 | Apr 29 | Apr 30 | May 1 | May 2 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | May | |||||||||
| 19 | 22 | 23 | 24 | 25 | 26 | 29 | 30 | 01 | 02 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Sarepta Therapeutics Stock
Is Sarepta Therapeutics Stock a Buy?
- Sarepta Therapeutics share price is 130.58 while SRPT 8-day simple moving average is 126.77, which is a Buy signal.
- The stock price of SRPT is 130.58 while Sarepta Therapeutics 20-day SMA is 123.47, which makes it a Buy.
- Sarepta Therapeutics 50-day simple moving average is 125.78 while SRPT share price is 130.58, making it a Buy technically.
- SRPT stock price is 130.58 and Sarepta Therapeutics 200-day simple moving average is 112.03, creating a Buy signal.
SRPT Technical Analysis vs Fundamental Analysis
Buy
53
Sarepta Therapeutics (SRPT)
is a Buy
Is Sarepta Therapeutics a Buy or a Sell?
-
Sarepta Therapeutics stock is rated a Buy
The current Sarepta Therapeutics [SRPT] share price is $130.58. The Score for SRPT is 53, which is 6% above its historic median score of 50, and infers lower risk than normal.
Sarepta Therapeutics Stock Info
Market Cap:
12.34B
Price in USD:
130.58
Share Volume:
2.02M
Sarepta Therapeutics 52-Week Range
52-Week High:
159.89
52-Week Low:
55.25
Buy
53
Sarepta Therapeutics (SRPT)
is a Buy
Sarepta Therapeutics Share Price Forecast
-
What is the Sarepta Therapeutics stock price today?
The Sarepta Therapeutics stock price is 130.58 USD today. -
Will SRPT stock go up or go down?
Sarepta Therapeutics> share price is forecast to RISE/FALL based on technical indicators -
Is Sarepta Therapeutics overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Sarepta Therapeutics is not overvalued.
Is Sarepta Therapeutics Stock a Buy?
- Sarepta Therapeutics share price is 130.58 while SRPT 8-day exponential moving average is 127.12, which is a Buy signal.
- The stock price of SRPT is 130.58 while Sarepta Therapeutics 20-day EMA is 125.01, which makes it a Buy.
- Sarepta Therapeutics 50-day exponential moving average is 123.64 while SRPT share price is 130.58, making it a Buy technically.
- SRPT stock price is 130.58 and Sarepta Therapeutics 200-day simple moving average is 116.53, creating a Buy signal.
Fundamental Analysis of Sarepta Therapeutics
Is Sarepta Therapeutics a good investment?
- Analysts estimate an earnings increase this quarter of $1.50 per share, an increase next quarter of $3.89 per share, an increase this year of $6.87 per share, and an increase next year of $5.50 per share.
Technical Analysis of Sarepta Therapeutics
Should I short Sarepta Therapeutics stock?
- SRPT Moving Average Covergence Divergence (MACD) indicator is 1.1, suggesting Sarepta Therapeutics is a Buy
- Sarepta Therapeutics Relative Strength Index (RSI) is 62.61, which suggest Sarepta Therapeutics is overbought
- The Bollinger Bands (25) for Sarepta Therapeutics is (119.44 - 129.14), which suggest Sarepta Therapeutics is a Buy
- The Bollinger Bands (100) for Sarepta Therapeutics is (105.04 - 131.84), which suggest Sarepta Therapeutics is a Buy
* Sarepta Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.